|
HS Code |
515314 |
| Chemical Name | 6-Methoxypyridine-2-Carboxylic Acid |
| Cas Number | 55449-77-1 |
| Molecular Formula | C7H7NO3 |
| Molecular Weight | 153.14 |
| Appearance | White to off-white powder |
| Melting Point | 175-178°C |
| Solubility | Soluble in water and organic solvents |
| Purity | Typically ≥98% |
| Storage Conditions | Store at room temperature, keep container tightly closed |
| Synonyms | 2-Carboxy-6-methoxypyridine |
| Smiles | COC1=NC(=CC=C1)C(=O)O |
As an accredited 6-Methoxypyridine-2-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White powder sealed in a 25g amber glass bottle, labeled "6-Methoxypyridine-2-Carboxylic Acid, 99%," with hazard and safety information. |
| Shipping | 6-Methoxypyridine-2-carboxylic acid is shipped in tightly sealed containers to prevent contamination and moisture absorption. It is labeled according to chemical safety regulations and transported under ambient conditions unless otherwise specified. Standard shipping includes proper documentation and adherence to chemical handling protocols to ensure safety and compliance during transit. |
| Storage | 6-Methoxypyridine-2-carboxylic acid should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area, away from incompatible materials such as strong oxidizing agents. Protect it from light and moisture. Ensure the storage area is clearly labeled and complies with local chemical safety regulations. Personal protective equipment should be used when handling the substance. |
Applications of 6-Methoxypyridine-2-Carboxylic Acid in Industrial Manufacturing6-Methoxypyridine-2-carboxylic acid supports key synthetic transformations across pharmaceutical, agrochemical, and specialty chemical sectors. As the original manufacturer, we supply this intermediate to downstream formulators who apply it in controlled environments to produce high-value end products with regulated purity and quality. 1. Pharmaceutical Intermediate for Antihypertensive APIsMajor pharmaceutical companies use this material as a building block for preparing several classes of antihypertensive active pharmaceutical ingredients (APIs), particularly pyridine-based Angiotensin II receptor blockers. This compound enables regioselective reactions in heterocyclic synthesis, offering critical masking and activation functions during stepwise assembly of the API core. The compound enters well-documented routes that require strict process control and trace residue analysis to fulfill ICH impurity standards, with batch records maintained to support regulatory submission. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Intermediate in Agrochemical Synthesis: Herbicides and FungicidesFormulators in the crop protection sector incorporate this pyridine derivative to produce selectivity-imparting ligands and core structures in new-generation herbicides and systemic fungicides. It participates in nucleophilic aromatic substitution and amide coupling reactions, forming part of the heterocyclic backbone modified for improved target specificity and environmental degradation profiles. Analysts use validated methods to assure absence of persistent contaminants, supported by traceability documentation for local and global registrations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Precursor to Specialty Electronic ChemicalsProducers of advanced electronic chemicals utilize this compound to synthesize high-purity pyridine derivatives required for dielectric modifiers, chelating agents, and surface passivation motifs in semiconductor fabrication. The material’s well-defined methoxy substitution facilitates precise functionalization and strict control of ionic contamination, critical for reliability in microelectronics. All process streams are monitored for trace residuals, and rigorous documentation supports audit trails required for global electronic component supply chains. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Synthesis Aid in Organic Photovoltaic (OPV) Materials ManufacturingManufacturers of organic electronics deploy this chemical as a precursor in the synthesis of electron donor-acceptor materials utilized in OPV layers. Its methoxy group offers a site for selective activation, expanding the chemical space for tuning optoelectronic properties of small molecule and polymer photovoltaic absorbers. Material handling requires closed-system operations and QC aligned with the high-purity specifications common to photovoltaic-grade inputs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 6-Methoxypyridine-2-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Work on the synthesis and refinement of 6-Methoxypyridine-2-Carboxylic Acid has always demanded unrelenting attention to purity, yield consistency, and transparency. Every kilogram produced in our facility represents the accumulated technical experience and ongoing dialogue between our research chemists and production teams. The structure itself, a pyridine ring harboring both a methoxy and a carboxylic acid group, might appear straightforward, but translating that simplicity into industrial reality brings with it persistent lessons and decisions unique to the floor of a manufacturer.
On a daily basis, our team manages raw material checks and batch reaction conditions. The selection of methylating agents and the care in temperature gradients influence not just the conversions, but also the downstream clarity in filtration and the color profile of the isolated solid. Small deviations at the reactor hardly go unnoticed; they find their voice later in how the product behaves during drying or the clarity of its final HPLC trace. Some labs gloss over these facts, but long-term customers know: if the solid leaves behind any residue in their flask, the story often traces right back to an overlooked parameter during production or phase separation.
With a molecular formula of C7H7NO3 and a consistent assay above 99% by HPLC, our 6-Methoxypyridine-2-Carboxylic Acid supplies a steady foundation for pharmaceutical intermediates, agrochemical synthesis, and polymer additives. Over years of manufacturing, patterns emerge in what chemists, development teams, and QC managers actually fight against, and it’s seldom just about “meeting specs.” By working on the factory side, we realize that routine impurities—such as residual starting pyridines or methylating byproducts—yield downstream headaches: colored solutions, sluggish reactions, unexpected peaks that haunt analysts during validation. Chemists value our material for what it avoids: secondary byproducts, excessive moisture, and variable particle sizes that slow down or contaminate sensitive syntheses.
In pharmaceutical and crop protection industries, starting materials set the pace and cleanliness for future steps. Several customers rely on our acid for the synthesis of triazolopyridines or as precursors in active ingredient research. Each time our acid runs cleanly on their end, with minimal need for extra pre-purification, we know our careful process control paid off. We keep chlorinated solvents away from workups to ensure residual halogen levels remain negligible; in the end, it’s a small ball of colorless, air-stable solid that stands between a clean chromatogram or an uphill struggle in product isolation for our clients.
Looking at the landscape of pyridine carboxylic acids, it is easy to see why our version of the 6-methoxy derivative catches ongoing interest. The methoxy group lends altered solubility and electronic effects compared to its plain, or methylated, siblings. Over the years, several material scientists and pharmaceutical developers tell us applications often fail to tolerate leftover methyl-sulfonates or ethereal solvents. Through repeated validation, we confirmed that our crystallization method not only scours away surface residues but also avoids introducing extractable impurities that plague powder processing lines. Having seen how deviations in purity can lead to batch rejection or regulatory headaches, we put substantial effort into both in-line and final-stage analytical controls.
Ethylene oxide or oxalyl chloride, sometimes employed in competing syntheses, risk leaving dangerous carryover. Our own approach, refined through hundreds of runs, never involves those methods. The result: each lot presents a repeatable mass spectrum, and nobody in the plant has to worry about hazardous off-gasses venting at unexpected moments. This kind of reliability—born out of lesson after lesson on scale-up mishaps—separates practical chemical manufacturing from mere trading. When putting pallets on a truck, it’s clear that each drum testifies to the care and repeated risk assessment under our roof.
Rarely does a month pass without a customer relating stories of hurdles overcome with our acid. These inspire everything from process tweaks to in-depth root cause assessments for outlier QC results. For instance, because early crystallization trials produced too many needle-shaped crystals with excessive fines, we adjusted both solvent ratios and anti-solvent addition rates. The improvement? Quicker filtration times on customer lines, less caking, and happier operators all around. When we see batch records from users reporting trouble-free handling, we know our everyday discipline at the filter press made a difference. Some clients face tight environmental discharge limits. By minimizing both inorganic salt residues and organic solvent levels in finished material, we spare them that extra step of post-purification or landfill cost for contaminated packaging.
We take pains to document and publish full impurity profiles and batch retest data. Pharmaceutical companies want more than just a neat certificate—they probe for trace level formylated byproducts, solvent residues, and even the rare methylpyridine isomers. Our protocols—developed hand in hand with contract laboratories—flag even low-concentration impurities. Internally, any deviation triggers both review and repetition of critical steps before the next batch runs. Manufacturing in reality looks like this: continuous feedback cycles between actual outcomes, real analytical results, and a willingness to halt, backtrack, or retool stubborn operations. Our repeat clients often remark that it’s this willingness to troubleshoot and document that gives them confidence in moving forward with their own synthetic campaigns.
In our experience, specifications matter only as much as the consistency with which they are met and the context in which the material is applied. For 6-Methoxypyridine-2-Carboxylic Acid, the industry often calls for tight limits on water content, clarity in melting point (routinely within a narrow two-degree spread), keto-enol tautomers, and precisely measured inorganic chloride levels. Each specification corresponds to either a familiar real-world production snag or a regulatory requirement mapped onto client-facing timelines. We have had to raise our own standards in direct response to the demands of cGMP and high-purity non-sterile manufacturing lines, learning from every isolated deviation and translating lessons into more robust analytical development.
Quality doesn’t happen by accident or keyword promises; it develops through cycles of process hazard analysis, small-batch piloting, routine scale-up, and relentless data review. Materials for regulatory submissions cannot tolerate missed specifications or spotty documentation. Our long-running partnerships arise out of this awareness; site audits, document review, and annual reviews all play into daily improvements. More than once, a collaborative lab project with a partner has pushed us to redesign an aspect of our purification process so that the next generation of powder achieves even lower impurity benchmarks. In these collaborations, much as on our own line, the proof always lies in the customer’s success—not in the theoretical promise of “high purity,” but in the practical use of our acid for reproducible and robust synthesis under tight timelines.
Regulations across continents place ever greater scrutiny on every aspect of substance production and use. Our direct experience with 6-Methoxypyridine-2-Carboxylic Acid means adapting both safety procedures and emission protocols. Several years ago, during an internal audit, we identified that open-system filtrations led to odor complaints and minor losses in volatile co-products. Now, closed-system transfers and advanced local extraction have become normal practice in the plant. The motivation? We want every person, from plant floor to QC lab, to trust in the safety of their working environment; and we must protect the communities around our facility from unnecessary exposure.
Our solvent recovery systems, installed in response to both internal goals and tightening disposal regulations, now allow for much higher material throughput without proportionate increase in waste. The acid’s particular sensitivity to certain polar solvents makes choice of washing agent critical; we find, for instance, that switching from methanol to isopropanol eliminates formation of trace methyl esters and improves environmental discharge numbers. Operating in today’s market means that every process tweak must take into account not just efficiency, but downstream compliance and stewardship. Our learning curve looks more like a line of plateaus than a single mountain peak—each solved problem opens up a new area for attention.
Having worked both on small-scale custom orders for early-stage research and hundred-kilogram batches for commercial clients, we see firsthand how raw material sourcing and reaction route selection impact long-term stability. Many aspiring manufacturers fall into the trap of chasing price cuts on starting materials, only to discover recurring problems with off-odor, minor color changes, or inconsistent solubility. Through several rounds of failed shortcut attempts, we learned that an apparently minor switch in starting pyridine can seed irregularities through every stage, right up to final packaging.
Selecting the right oxidant for ring functionalization, in our workflow, turned into one of the most critical choices. Incomplete oxidation introduces unreacted precursors that seem minor in isolation but amplify during subsequent derivatization on the customer’s end. There’s no substitute for stress-testing every input—not just on paper or in single trials, but across dozens of commercial runs. By sticking to long-tested, traceable sources and performing third-party analytics on each drum of key reagents, we insulate both ourselves and end users from unexpected upsets. As a manufacturer, our long-game perspective stresses that repeatable outcomes depend less on document templates and more on every drum, every valve, and every change logged and questioned on the production floor.
Every so often, our production experts attend industry conferences, not just to showcase achievements but to collect frank feedback. More than a few visitors—representing formulators, process chemists, or regulatory officers—share stories of delayed project timelines due to unpredictable intermediate quality or frustrating supply interruptions. The theme emerges: stable access to trusted intermediates like 6-Methoxypyridine-2-Carboxylic Acid forms the backbone of both routine operations and innovation in fine chemicals and pharmaceuticals.
By maintaining a stable production pipeline, streamlined inventory management, and integrated logistics, we do more than deliver a product; we help shield our customers from the costliest surprise in chemical manufacturing: downtime. Each time a formulation or process is forced to pause (pending additional analysis, impurity investigation, or purity-driven procurement delays), entire project calendars slip. Over the years, manufacturers like us have observed this domino effect—one misstep in the purity or reliability chain, and the consequences cascade outward. Our commitment to regular shipment schedules, often built on long-term supply agreements, represents a shared investment in every customer’s workflow stability.
Manufacturing 6-Methoxypyridine-2-Carboxylic Acid today presents new puzzles every year. Regulatory guidelines update as new analytical technologies become available. Market needs shift toward ever cleaner, more precisely documented materials. Each innovation in synthetic chemistry outside our walls creates possible new derivatives, functionalizations, and uses—demanding re-examination of the tools and knowledge inside our plant.
Our R&D group now collaborates with outside labs on detecting and controlling ultra-trace contaminants and identifying best-fit derivatives for new market applications. At the same time, process engineers at our site push for cleaner energy use, improved personal safety protocols, and greater automation in monitoring and batch record-keeping. The competitive edge for a real manufacturer comes not from fleeting price wars or speculative purity promises, but from established capability and the humility to adapt. Looking forward, our goal remains unwavering: to deliver a material that stands up in the lab, on the balance, and—most importantly—through years of repeated use in demanding applications.
Our decades-long work on 6-Methoxypyridine-2-Carboxylic Acid has forged relationships across industries and continents. With every batch shipped, every technical support exchange, and every audit passed or lesson absorbed, we reinforce our core belief that chemical manufacturing succeeds not through slogans, but through accountability, transparency, and ongoing improvement. Whether the challenge relates to purity, process robustness, or regulatory adaptation, we approach it from the ground up, shaped by our own hard-earned perspective as actual makers of this vital intermediate.